S., Canada , Europe , South america , additionally the China-Pacific part On the EMBARKThe Astellas- and Pfizer-led Phase step 3, randomized, double-blind, placebo-controlled, multi-national demo enrolled step one,068 customers which have nonmetastatic hormonal- (or castration-) sensitive prostate cancers (nmHSPC otherwise nmCSPC) with a high-risk BCR at the internet sites from the You. Customers who